Working… Menu

Continuation Protocol to Protocol BBCO-001 (HOPEMD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02328482
Recruitment Status : Completed
First Posted : December 31, 2014
Last Update Posted : July 17, 2019
Information provided by (Responsible Party):
Bioblast Pharma Ltd.

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : October 2017
Actual Study Completion Date : December 2017